Eric Easom - Nov 18, 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Stock symbol
ANTX
Transactions as of
Nov 18, 2024
Transactions value $
$49,970
Form type
4
Date filed
11/18/2024, 08:51 PM
Previous filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $50K +50K +4.92% $1.00 1.07M Nov 18, 2024 See Footnote F1
holding ANTX Common Stock 101K Nov 18, 2024 Direct F2
holding ANTX Common Stock 97.1K Nov 18, 2024 See Footnote F3
holding ANTX Common Stock 97.1K Nov 18, 2024 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
F2 Includes 99,000 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.
F3 Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
F4 Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.